GSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRsGSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRsGSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRs

GSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRs

No trades
See on Supercharts

GSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRs forum


GSK Break to the downside coming this week since an hedge order came in for 4/19 exp.

Entry below $40.51

Trade becomes invalid on any gap and go or around the $40.98 area

GSK jemperil clinical trial forecasted to be complete by end of June. It treats endometrial cancer